EMERYVILLE, Calif., Oct. 24, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report third quarter 2024 financial results on Thursday, November 7, 2024, after the U.S....
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments